What's Next for World Hematology and Flow Cytometry Analyzer and Reagent Markets 2022: Continued Advances in Molecular Diagnostics, Monoclonal Antibodies, Lasers and IT Drive Sector - ResearchAndMarkets.com
22 Nov 2022
Diagnostic Reagents
DUBLIN--(BUSINESS WIRE)--The "2022 What's Next for World Hematology and Flow Cytometry Analyzer and Reagent Markets" report has been added to ResearchAndMarkets.com's offering.
'2022 What\'s Next for World Hematology and Flow Cytometry Analyzer and Reagent Markets'
This survey from the publisher provides granular data and analysis not available elsewhere. The survey is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities emerging in the global hematology and flow cytometry markets during the next five years.
Rationale
Continued advances in molecular diagnostics, monoclonal antibodies, lasers and IT, as well as growing understanding of immunologic forces regulating systemic diseases, will have a profound impact on the hematology and flow cytometry markets worldwide. New molecular diagnostic and monoclonal antibody tests will facilitate existing procedures and provide basis for sensitive, specific and simple assays. The introduction of smaller and easy-to-operate laser systems will further expand applications of flow cytometry to routine clinical laboratories. Further advances in IT will reduce the cost of instrument manufacture, service warranty, and permit development of self-troubleshooting, auto-calibration and other advanced features. Presently tedious analyses of chromosomal abnormalities, DNA content, and lymphocyte subsets will become more automated and routine.
Geographic Regions and Countries
Asia-Pacific
Australia, Bangladesh, China, Hong Kong, India, Indonesia, Japan, Malaysia, Myanmar, New Zealand, Pakistan, Philippines, Singapore, South Korea, Taiwan, Thailand, Turkey, Vietnam
Europe
Albania, Austria, Belarus, Belgium, Bulgaria, Croatia, Cyprus, Czech Republic, Denmark, Estonia, Finland, France, Georgia, Germany, Greece, Hungary, Iceland, Ireland, Italy, Kazakhstan, Latvia, Lithuania, Malta, Moldova, Netherlands, Norway, Poland, Portugal, Romania, Russia, Serbia, Slovakia, Slovenia, Spain, Sweden, Switzerland, UK, Ukraine
Latin America
Argentina, Bolivia, Brazil, Chile, Colombia, Costa Rica, Cuba, Dominican Republic, Ecuador, El Salvador, Guatemala, Haiti, Honduras, Jamaica, Mexico, Nicaragua, Panama, Paraguay, Peru, Puerto Rico, Uruguay, Venezuela
Middle East
Bahrain, Iran, Iraq, Israel, Jordan, Kuwait, Lebanon, Oman, Qatar, Saudi Arabia, United Arab Emirates
North America
Canada, Mexico, USA
New product development opportunities with significant market appeal.
Alternative market penetration strategies.
Potential market entry barriers and risks.
Market Segmentation Analysis
Sales and market share estimates of leading hematology and flow cytometry product suppliers in major countries.
Specimen, test and sales forecasts for over 40 procedures.
Sales and Market Share Analysis
Sales and market shares of major instrument and reagent suppliers in major countries.
Hematology Tests Analyzed in the Report
CBC + 5-Part Differential, Manual Differential/Review, Hematocrit (Automated, Manual), Hemoglobin (Automated, Manual), Sedimentation Rate, Reticulocytes, WBC (Automated, Manual), Platelets (Automated, Manual), Bone Marrow Analysis, RBC, Eosinophils
Flow Cytometry Tests Analyzed in the Report
Reviews of current instrumentation technologies, and features of leading hematology, flow cytometry, platelet aggregation and sedimentation rate analyzers.
The report features analyzers marketed by Abbott, Beckman Coulter/Danaher, Becton Dickinson, Biocode Hycel, CellaVision, Diesse Ves Matic, Drew-Scientific, Horiba, Medica, Menarini, Nihon Kohden, Polymedco, Siemens, Sysmex and other suppliers.
Technology Review
Assessment of current and emerging technologies and their potential market applications.
Companies developing or marketing new technologies and products by test.
Competitive Assessments
Strategic profiles of major suppliers and emerging market entrants.
The companies analyzed in the report include:
Horiba
Nihon Kohden
Sysmex
For more information about this report visit https://www.researchandmarkets.com/r/5a9wwl
For more details,please visit the original website
The content of the article does not represent any opinions of Synapse and its affiliated companies. If there is any copyright infringement or error, please contact us, and we will deal with it within 24 hours.
Organizations
Targets
Drugs
-Hot reports
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Leverages most recent intelligence information, enabling fullest potential.